EMA OKs Seven New Drugs But Delivers Another Blow To Emmaus

 
• By Neena Brizmohun

Seven new drugs have this week moved closer to gaining EU approval following positive recommendations from the European Medicines Agency, but Emmaus’ glutamine product has fared less well and the company is considering another route for getting the drug to sickle cell disease patients in Europe

Shopping cart loaded with pills on pink background. The concept of medicine and the sale of drugs. Copy space. - Image
More new drugs are nearing the EU market. • Source: Shutterstock

More from Europe

More from Geography